Bookmark and Share

Compound Summary for: CID 6450551

axitinib

Also known as: 319460-85-0; AG-013736; Inlyta; AG 013736; UNII-C9LVQ0YUXG; AG013736; S1005_Selleck; AG-013736, Axitinib; AG-13736
Molecular Formula: C22H18N4OS   Molecular Weight: 386.46952   InChIKey: RITAVMQDGBJQJZ-FMIVXFBMSA-N
Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3. Axitinib is marketed under the name Inlyta®, and if one previous systemic therapy for kidney cell cancer has failed, axitinib is indicated.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show first sub-section only
Use and Manufacturing
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _